Ansell JE, Buttaro JL, Thomas OV, Knowlton CH. 1997. The anticoagulation guidelines task force: Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Ann Pharmacother 31:604.
Baran RW, Crumlish K, Patterson H, et al. 1999. Improving outcomes of community-dwelling older patients with diabetes through pharmacist counseling. Am J Health Syst Pharm 56:1535.
Berringer R, Shibely MC, Cary CC, et al. 1999. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Pharm Assoc 39:791.
Centers for Medicare and Medicaid Services. 2003. What is waived testing? Available at www.fda.gov/cdrh/clia; accessed on June 14, 2003.
Christensen DB, Holmes G, Fassatt WE, et al. 1999. Influence of a financial incentive on cognitive services: CARE project design/implementation. J Am Pharm Assoc 39:629.
Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. 1998. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 32:636.
Cowper PA, Weinberger M, Hanlon JT, et al. 1998. The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy 18:327.
Davis FB, Sczupak CA. 1979. Outpatient oral anticoagulation: Guidelines for long-term management. Postgrad Med 66:100.
Dobie RL, Rascati KL. 1994. Documenting the value of pharmacist interventions. Am Pharm 34:50.
Elliott ME, Meek PD, Kanous NL, et al. 2002. Osteoporosis screening by community pharmacists: Use of national osteoporosis foundation resources. J Am Pharm Assoc 42:101.
Ferro LA, Marcrom RE, Garrelts L, et al. 1998. Collaborative practice agreements between pharmacists and physicians. J Am Pharm Assoc 38:655.
Furmaga EM. 1993. Pharmacist management of a hyperlipidemia clinic. Am J Hosp Pharm 50:91.
Grainger-Rousseau TJ, Miralles MA, Hepler CD, et al. 1997. Therapeutic outcomes monitoring: Application of pharmaceutical care guidelines to community pharmacy. J Am Pharm Assoc NS37:647.
Hanlon JT, Weinberger M, Samsa GP, et al. 1996. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 100: 428.
Hawkins DW, Fiedler FP, Douglas HL, Eschbach RC. 1979. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm 36:321.
Herborg H, Sondergaard B, Froekjaer B, et al. 2001. Improving drug therapy for patients with asthma: 2. Use of antiasthma medications. J Am Pharm Assoc 41:551.
Jaber LA, Halapy H, Fernet M, et al. 1996. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 30:238.
Kennedy DT, Giles JT, Chang ZG, et al. 2002. Results of a smoking cessation clinic in community pharmacy practice. J Am Pharm Assoc 42:51.
Knapp KK, Katzman H, Hambright JS, Albrant DH. 1998. Community pharmacist interventions in a capitated pharmacy benefit contract. Am J Health Syst Pharm 55:1141.
Knoell DL, Pierson JF, Marsh CB, et al. 1998. Measurement of outcomes in adults receiving pharmaceutical care in a comprehensive asthma outpatient clinic. Pharmacotherapy 18:1365.
Knowlton CH, Thomas OV, Willamson A, et al. 1999. Establishing community-based anticoagulation education and monitoring programs. J Am Pharm Assoc 39:368.
Madejski RM, Madejski TJ. 1996. Cholesterol screening in a community pharmacy. J Am Pharm Assoc NS36: 243.
McCurdy M. 1993. Oral anticoagulation monitoring in a community pharmacy. Am Pharm 10:61.
McDonough RP. 1996. Interventions to improve patient pharmaceutical care outcomes. J Am Pharm Assoc NS36:453.
McDonough RP, Doucette WR. 2001. A conceptual framework for collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc 41: 682.
McKenney JM, Brown ED, Necsary R, Reavis HL. 1978. Effect of pharmacist drug monitoring and patient education on hypertensive patients. Contemp Pharm Pract 1:50.
McKenney JM, Sliining JM, Henderson HR, et al. 1973. The effect of clinical pharmacy services on patients with essential hypertension. Circulation 48:1104.
Norton JL, Gibson DL. 1996. Establishing an outpatient anticoagulation clinic in a community hospital. Am J Health Syst Pharm 53:1151.
Pauley TR, Magee MJ, Cury JD. 1995. Pharmacists-managed physician-directed asthma management program reduces emergency department visits. Ann Pharmacother 29:5.
Petty DR, Zermansky AG, Raynor DK, et al. 2002. Clinical medication review by a pharmacists of elderly patients on repeat medications in general practice: Pharmacist interventions and review outcomes. Int J Pharm Pract 10:39.
Reinders TP, Rush DR, Baumgartner RP, Graham AW. 1975. Pharmacist's role in management of hypertensive patients in an ambulatory care clinic. Am J Hosp Pharm 32:590.
Reinders TP, Steinke WE. 1979. Pharmacist management of anticoagulant therapy in ambulant patients. Am J Hosp Pharm 36:645.
Rosenthal W. 2000. Establishing a pharmacy-based laboratory service. J Am Pharm Assoc 40:146.
Rupp MT. 1988. Evaluation of prescribing errors and pharmacist interventions in community practice: An estimate of “value added.” Am Pharm NS28:766.
Rupp MT. 1992. Value of community pharmacists' interventions to correct prescribing errors. Ann Pharmacother 26:1580.
Rupp MT, DeYoung M, Schondelmeyer SW. 1992. Prescribing problems and pharmacist interventions in community practice. Med Care 30:926.
Rupp MT, McCallian DJ, Sheth KK. 1997. Developing and marketing a community pharmacy–based asthma management program. J Am Pharm Assoc NS37:694.
Schilling KW. 1977. Pharmacy program for monitoring diabetic patients. Am J Hosp Pharm 34:1242.
Simpson SH, Johnson JA, Tsuyuki RT. 2001. Economic impact of community pharmacist intervention in cholesterol risk management: An evaluation of the study of cardiovascular risk intervention by pharmacists. Pharmacotherapy 21:627.
Smith DH, Fassatt WE, Christensen DB. 1999. Washington State CARE project: Downstream cost changes associated with the provision of cognitive services by pharmacists. J Am Pharm Assoc 39:650.
Strand LM, Cipolle RJ, Morley PC. 1988. Documenting the clinical pharmacist's activities: Back to basics. Drug Intell Clin Pharm 2:63.
Strand LM, Cipolle RJ, Morley PC. 1992. Pharmaceutical care: An introduction. In Current Concepts. Kalamazoo, MI: Upjohn Company, p. 1.
Swain JH, Macklin R. 2001. Individualized diabetes care in a rural community pharmacy. J Am Pharm Assoc 41:458.
Tice B, Phillips CR. 2002. Implementation and evaluation of a lipid screening program in a large chain pharmacy. J Am Pharm Assoc 42:413.
Tiggelaar JM. 1987. Protocols for the treatment of essential hypertension and type II diabetes mellitus by pharmacists in ambulatory care clinics. Drug Intell Clin Pharm 21:521.
Tsukuki RT, Johnson JA, Teo KK, et al. 1999. Study of cardiovascular risk intervention by pharmacists (SCRIP): A randomized trial design of the effect of community pharmacist intervention program on serum cholesterol risk. Ann Pharmacother 33:910.